Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine

Eunah Kang, Kumar Vedantham, Xin Long, Maria Dadara, Il Keun Kwon, Michael Sturek, Kinam Park

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX) is a highly selective antagonist of the adenosine A1 receptor (A1R). The A 1R mediates mitogenic effects of adenosine in coronary artery smooth muscle cells (CASMC). DPCPX plays a role as an antimitogen and reduces CASMC proliferation by the blockage of A1R. A drug-eluting stent (DES) loaded with DPCPX was prepared. The water solubility of DPCPX is 1.6 μg/mL at pH 3-9, and 38.1 ± 2.3 μg/mL at pH 11. A series of DPCPX-eluting stents were formulated in polyurethane (PU) films with different dose densities and film thicknesses. The release of DPCPX from the PU-coated stents was nearly linear. The release rate and duration were effectively controlled by adjusting the film thickness with the same drug concentration. The eluted DPCPX from the PU films was effective in preventing CASMC proliferation, regardless of stimulation by 2-chloro-N-6-cyclopentyladenosine (CCPA), a highly selective A1R agonist. A1R specific antagonist DPCPX was effective in preventing CASMC proliferation and holds great promise for intracoronary delivery from DESs to test the role of the A1R signaling pathway for prevention of in-stent restenosis.

Original languageEnglish (US)
Pages (from-to)1110-1117
Number of pages8
JournalMolecular Pharmaceutics
Volume6
Issue number4
DOIs
StatePublished - Aug 3 2009

Fingerprint

Xanthine
Drug-Eluting Stents
Signal Transduction
Smooth Muscle Myocytes
Polyurethanes
Coronary Vessels
Stents
2-chloro-N(6)cyclopentyladenosine
Cell Proliferation
Adenosine A1 Receptor Antagonists
Adenosine
Solubility
Water

Keywords

  • 1,3-Dipropyl-8-cyclopentyl xanthine
  • Adenosine receptor
  • Coronary artery smooth muscle cells
  • Drug eluting stent
  • Restenosis

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine. / Kang, Eunah; Vedantham, Kumar; Long, Xin; Dadara, Maria; Kwon, Il Keun; Sturek, Michael; Park, Kinam.

In: Molecular Pharmaceutics, Vol. 6, No. 4, 03.08.2009, p. 1110-1117.

Research output: Contribution to journalArticle

Kang, Eunah ; Vedantham, Kumar ; Long, Xin ; Dadara, Maria ; Kwon, Il Keun ; Sturek, Michael ; Park, Kinam. / Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine. In: Molecular Pharmaceutics. 2009 ; Vol. 6, No. 4. pp. 1110-1117.
@article{24f62afa15e34c9eac22a64214aa002f,
title = "Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine",
abstract = "1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX) is a highly selective antagonist of the adenosine A1 receptor (A1R). The A 1R mediates mitogenic effects of adenosine in coronary artery smooth muscle cells (CASMC). DPCPX plays a role as an antimitogen and reduces CASMC proliferation by the blockage of A1R. A drug-eluting stent (DES) loaded with DPCPX was prepared. The water solubility of DPCPX is 1.6 μg/mL at pH 3-9, and 38.1 ± 2.3 μg/mL at pH 11. A series of DPCPX-eluting stents were formulated in polyurethane (PU) films with different dose densities and film thicknesses. The release of DPCPX from the PU-coated stents was nearly linear. The release rate and duration were effectively controlled by adjusting the film thickness with the same drug concentration. The eluted DPCPX from the PU films was effective in preventing CASMC proliferation, regardless of stimulation by 2-chloro-N-6-cyclopentyladenosine (CCPA), a highly selective A1R agonist. A1R specific antagonist DPCPX was effective in preventing CASMC proliferation and holds great promise for intracoronary delivery from DESs to test the role of the A1R signaling pathway for prevention of in-stent restenosis.",
keywords = "1,3-Dipropyl-8-cyclopentyl xanthine, Adenosine receptor, Coronary artery smooth muscle cells, Drug eluting stent, Restenosis",
author = "Eunah Kang and Kumar Vedantham and Xin Long and Maria Dadara and Kwon, {Il Keun} and Michael Sturek and Kinam Park",
year = "2009",
month = "8",
day = "3",
doi = "10.1021/mp8002623",
language = "English (US)",
volume = "6",
pages = "1110--1117",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine

AU - Kang, Eunah

AU - Vedantham, Kumar

AU - Long, Xin

AU - Dadara, Maria

AU - Kwon, Il Keun

AU - Sturek, Michael

AU - Park, Kinam

PY - 2009/8/3

Y1 - 2009/8/3

N2 - 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX) is a highly selective antagonist of the adenosine A1 receptor (A1R). The A 1R mediates mitogenic effects of adenosine in coronary artery smooth muscle cells (CASMC). DPCPX plays a role as an antimitogen and reduces CASMC proliferation by the blockage of A1R. A drug-eluting stent (DES) loaded with DPCPX was prepared. The water solubility of DPCPX is 1.6 μg/mL at pH 3-9, and 38.1 ± 2.3 μg/mL at pH 11. A series of DPCPX-eluting stents were formulated in polyurethane (PU) films with different dose densities and film thicknesses. The release of DPCPX from the PU-coated stents was nearly linear. The release rate and duration were effectively controlled by adjusting the film thickness with the same drug concentration. The eluted DPCPX from the PU films was effective in preventing CASMC proliferation, regardless of stimulation by 2-chloro-N-6-cyclopentyladenosine (CCPA), a highly selective A1R agonist. A1R specific antagonist DPCPX was effective in preventing CASMC proliferation and holds great promise for intracoronary delivery from DESs to test the role of the A1R signaling pathway for prevention of in-stent restenosis.

AB - 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX) is a highly selective antagonist of the adenosine A1 receptor (A1R). The A 1R mediates mitogenic effects of adenosine in coronary artery smooth muscle cells (CASMC). DPCPX plays a role as an antimitogen and reduces CASMC proliferation by the blockage of A1R. A drug-eluting stent (DES) loaded with DPCPX was prepared. The water solubility of DPCPX is 1.6 μg/mL at pH 3-9, and 38.1 ± 2.3 μg/mL at pH 11. A series of DPCPX-eluting stents were formulated in polyurethane (PU) films with different dose densities and film thicknesses. The release of DPCPX from the PU-coated stents was nearly linear. The release rate and duration were effectively controlled by adjusting the film thickness with the same drug concentration. The eluted DPCPX from the PU films was effective in preventing CASMC proliferation, regardless of stimulation by 2-chloro-N-6-cyclopentyladenosine (CCPA), a highly selective A1R agonist. A1R specific antagonist DPCPX was effective in preventing CASMC proliferation and holds great promise for intracoronary delivery from DESs to test the role of the A1R signaling pathway for prevention of in-stent restenosis.

KW - 1,3-Dipropyl-8-cyclopentyl xanthine

KW - Adenosine receptor

KW - Coronary artery smooth muscle cells

KW - Drug eluting stent

KW - Restenosis

UR - http://www.scopus.com/inward/record.url?scp=68249100659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249100659&partnerID=8YFLogxK

U2 - 10.1021/mp8002623

DO - 10.1021/mp8002623

M3 - Article

C2 - 19432454

AN - SCOPUS:68249100659

VL - 6

SP - 1110

EP - 1117

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 4

ER -